«The issue
of continuing therapy until all doses are done is an old wives» tale,» Spellberg says.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or
continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs);
continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell
therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other
therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Further, we believe R&D NewCo will be strongly positioned to
continue Actelion's legacy
of innovation and look forward to collaborating on the development
of cutting - edge new
therapies.»
Galapagos (GLPG)- Partnered assets
continue to progress in the clinic, its IPF program offers optionality, efforts in cystic fibrosis to develop a triple combination
therapy should not be underestimated and Gilead (GILD)- partnered filgotinib could have peak sales
of over $ 3 billion alone.
The injection will bankroll the
continuing technical development
of the firm's first LIGHT system and its installation at the Harley Street Proton
Therapy Centre
Among its top holdings, Intra-Cellular
Therapies (ITCI) was up more than 11 %,
continuing a run that has helped the stock double in price since the end
of August following positive data on late - stage experimental schizophrenia drug candidate ITI - 007.
While we feel the best interests
of the child in question are paramount, the interests
of society, including the other children who might have used this valuable resource, can not be ignored, especially when non-medically indicated painful and futile
therapies are
continued on children due to the expectation
of miraculous intervention.
Turning to the second category
of therapies, it is important to be cognizant
of the fact that some alcoholics can not halt their compulsive drinking for long, even with the help
of initial detoxification procedures and
continuing affiliation with AA.
If ESCR using «excess» embryos from IVE»
continues, the next step will likely be the pursuit
of such «therapeutic» cloning — the creation
of embryos through somatic cell nuclear transfer (SCNT) to provide individually tailored stem cell
therapies.
A Long Island church
of which I was pastor used a modified
therapy group approach in its
continuing program
of child - study for mothers
of preschoolers.
(3) The rapid increase in the influence
of his approach since his death is evident in the development
of several gestalt
therapy training institutes and the burgeoning writings
of creative therapists who
continue to modify, amplify, and enrich his original formulation.
The goals
of growth in gestalt
therapy are really directions
of continuing change.
What was keeping me sober was my
continuing support
of AA buddies,
therapy and behavioral principles and being
of service to fellow man.
The working concepts and methods
of the systemic
therapies may well give us resources for fostering the
continuing self - renewal which is needed within our people - serving institutions and wider systems.
7 is an illustration
of how a modified
therapy approach can be used in a
continuing group for parents
of preschoolers.
Four motifs in Rogers» approach to counseling and
therapy represent
continuing contributions to the psychotherapeutic enterprise — his growth orientation; his emphasis on listening responsively and acceptingly to clients; his awareness that the emotional quality
of the therapeutic relationship is the key to whether or not it nurtures growth; and his commitment to subjecting the therapeutic process and outcome to careful research.
Lowering the dietary intake
of FODMAPs
continues to be the first line
therapy for patients experiencing GI symptoms.
The hyperbaric oxygen
therapy he received could be a major breakthrough in the treatment
of athletes (or anyone) suffering from concussions or concussion - related issues, and Bryan
continuing to receive
therapy while successfully keeping his career as a wrestler going would only add to that breakthrough.
If being on medication can help me feel a little better while I
continue to go to
therapy and focus on sleep, exercise and taking better care
of myself, then I will do it.
For me the work is worth it, it is part
of the reward, because I find encouragement in watching my skills
continue to improve, I find
therapy in the rituals, I find physical comfort and convenience from my favorite baby gear item.
Alyssa began her cranioscaral
therapy training in the Spring
of 2016 and looks forward to
continuing her training in the coming months with the ultimate goal
of working in Pediatrics as well as Prenatal, Birth and Post-Partum care.
After careful consideration
of pros / cons, many choose to
continue with hormone replacement
therapy.
And that's why, once you achieve a remission, almost always you
continue with additional
therapy for a period
of time.
The speech - language pathologist will do an evaluation to determine whether your child's stutter is likely to
continue and can work with your child on
therapy that will lessen the severity
of stuttering.
As a member
of Play
Therapy Ireland and the Psychological Society
of Ireland, she adheres to strict codes
of practice, including clinical supervision,
continuing professional development and clinical governance, as well as to Ireland's child protection guidelines Children First.
For several years, she was a Test Site Administrator and
continues to review proposals for the NATA convention program, is an NATA Athletic Training Education Journal Advisory Board committee member, and reviews manuscripts for the Internal Journal
of Athletic
Therapy and Training.
Speech and / or language
therapy may
continue throughout a student's school years either in the form
of direct
therapy or on a consultant basis.
The Symposium offered six Board
of Certification (BOC)
continuing education units (CEU's) for athletic trainers and included three Evidence Based Practice (EBP) CEU's sponsored by CPRS Physical
Therapy.
Whether
continued tocolysis after 48hours
of rescue tocolysis improves neonatal outcome is unproven.To evaluate the effectiveness
of maintenance tocolytic
therapy with oral nifedipine on the reduction
of adverse neonatal outcomes and the prolongation
of pregnancy by performing an individual patient data meta - analysis (IPDMA).
CranioSacral
Therapy continues to support families at all stages
of life.
APT further designates individuals, organizations, and companies as Approved ProvidersTM
of APT - approved play
therapy continuing education in order to:
Lea would like to
continue to spread the word play
therapy throughout the state
of Oklahoma!
APT offers the designation
of RPT and RPT - S credentials to individuals who have provided APT with documentation that they have: (a) a traditional mental health graduate or higher degree; (b) been licensed by one or more applicable licensing authorities and / or certified by the primary certification authorities; (c) completed a minimum number
of Play
Therapy training and supervision clock hours; and (d) completed the requisite
continuing education hours.
As the
therapy continued into the 6th month the sides
of her head appeared within normal limits and the back
of her head was also perfectly curved.
It is an unfortunate fact
of life that large scale tragedies will
continue to occur, as the earthquakes in Japan and the horrific events in Norway attest, so Elizabeth's advice to other psychiatrists looking to help survivors and rescuers in future events would be to not focus on the
therapy they have learned but instead invest time in listening and providing comfort by simple human contact.
While the combination
therapies block off the principal pathway that cancer cells use to fuel their growth, the cells come to bypass this blockade and, like vehicles on a detour route, make use
of additional pathways to
continue growing and spreading.
Despite months
of talk
therapy, the nightmares
continued, and Bledsoe grew desperate.
Because so many
of the patients in the early testing showed significant long - lasting responses, the study was
continued and the FDA granted the drug «breakthrough
therapy» status, allowing it to be fast - tracked for approval.
The panel
continues to recommend a three - part
therapy that contains AZT, or the HIV inhibitor called TDF, in the place
of stavudine, which can alter fat metabolism and cause nerve damage.
The scientists conclude that in mice «well - timed treatment with rIL - 27 improved lung injury and accelerated recovery without affecting viral clearance» and
continue «these data demonstrate that IL - 27 has a unique role in controlling immunopathology without impacting on host defense, and might therefore represent a promising candidate for immunomodulatory
therapy of viral pneumonia.»
There already has been great effort to elucidate the mechanisms
of gene expression regulation, but it will be important to
continue research to fully realize the potential
of these epigenetic
therapies and their applications in clinical settings.
HIV also hides in cells and
continues to undermine the host's immune system despite antiretroviral
therapy that has improved the outlook
of those with AIDS.
One
of the biggest challenges that remains is making sure
therapies continue to work with patients in the long term and pinpointing if that means cancer
therapies should be administered in combination or deployed in a specific order for certain patients.
These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval
of Genentech's drug Avastin for breast cancer and advances in the use
of gene
therapy, despite some setbacks;
continuing progress in research on stem cells; the emergence
of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.
«This greater than expected survival in older patients selected for operative
therapy is noteworthy,» said Dr. Fernandez, «especially considering that the prevalence
of lung cancer is expected to increase as the population
continues to grow older and more people survive into old age.»
The investigators found that women were less likely to have started taking statin
therapy (81.9 percent
of women vs. 87.7 percent
of men) or to have
continued statin
therapy (67.0 percent
of women versus 71.4 percent
of men).
He treated nine men who had been hiv positive for 20 years or more, were on combination antiretroviral
therapy, and yet had persistently low counts
of the cd4 cells, signaling the
continued presence
of the virus.
She
continued: «Therefore, in further studies, we should investigate how and at what point DPP4 inhibitors can be used in diabetes
therapy to prevent the development
of non-alcoholic fatty liver disease.»
Six months after completing
therapy, 86 percent
of the patients were alive with
continued responses.
Consistent with the national trend, the number
of women in the Kaiser plan taking hormone replacement
therapy plummeted in 2002; from 2003 to 2004, breast cancer incidence slid 18 percent then
continued on a downward trajectory.